Nursing Elites

1. The nurse is caring for a client on amiodarone. What adverse effect is the nurse most concerned about?

• A. Pulmonary toxicity
• B. Liver toxicity
• C. Thyroid dysfunction
• D. Renal dysfunction

Correct answer: A

Rationale: The correct answer is A, Pulmonary toxicity. Amiodarone is known to cause pulmonary toxicity, which can be serious and even fatal in some cases. This adverse effect includes interstitial pneumonitis, pulmonary fibrosis, and acute respiratory distress syndrome. Monitoring for symptoms such as cough, dyspnea, and fever is crucial. Choices B, Liver toxicity, C, Thyroid dysfunction, and D, Renal dysfunction, are incorrect because while amiodarone can also affect the liver, thyroid, and kidneys, the most concerning adverse effect that requires immediate attention and monitoring is pulmonary toxicity.

2. What is the procedure where a catheter is used to open a blocked or narrowed coronary artery, often involving the placement of a stent?

• A. Angioplasty
• B. Valve replacement
• C. Stent placement
• D. Coronary artery bypass graft (CABG)

Correct answer: A

Rationale: The correct answer is Angioplasty. Angioplasty is a procedure where a catheter is used to open a blocked or narrowed coronary artery, often involving the placement of a stent to keep the artery open and improve blood flow to the heart. Choice B, Valve replacement, is incorrect as it involves replacing a heart valve, not opening a blocked artery. Choice C, Stent placement, is similar to angioplasty but not as specific, as it does not involve the catheter-based procedure. Choice D, Coronary artery bypass graft (CABG), is a different procedure where blocked arteries are bypassed using a blood vessel from another part of the body.

3. A client on a beta blocker has a heart rate of 52 bpm. What is the nurse’s priority action?

• A. Hold the beta blocker and notify the healthcare provider.
• B. Administer the beta blocker as ordered.
• C. Increase the dose of the beta blocker.
• D. Continue to monitor the client and reassess in 30 minutes.

Correct answer: A

Rationale: The correct answer is to hold the beta blocker and notify the healthcare provider. A heart rate of 52 bpm is low, and beta blockers can further decrease the heart rate, potentially causing harm. Therefore, withholding the medication and promptly informing the healthcare provider is crucial for further assessment and possible adjustment of the treatment plan. Administering the beta blocker as ordered (Choice B) can exacerbate the bradycardia. Increasing the dose of the beta blocker (Choice C) would further suppress the heart rate. Continuing to monitor the client and reassessing in 30 minutes (Choice D) might delay necessary interventions and increase the risk of complications in a client with a heart rate of 52 bpm.

4. What are the pressure-sensitive structures located in the aortic and carotid bodies called?

• A. Baroreceptors
• B. Chemoreceptors
• C. Nociceptors
• D. Mechanoreceptors

Correct answer: A

Rationale: Baroreceptors are the correct answer. Baroreceptors are specialized sensory receptors that detect changes in pressure within blood vessels. They are primarily located in the aortic arch and carotid sinuses, where they play a crucial role in regulating blood pressure. Chemoreceptors (Choice B) are receptors that detect chemical changes, not pressure changes. Nociceptors (Choice C) are responsible for detecting painful stimuli. Mechanoreceptors (Choice D) respond to mechanical stimuli such as touch, pressure, and vibration, but they are not specifically located in the aortic and carotid bodies.

5. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?

• A. Increase the dose of warfarin
• B. Administer vitamin K
• C. Monitor for signs of bleeding
• D. Hold the next dose and notify the healthcare provider

Correct answer: A

Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.

Similar Questions